261 related articles for article (PubMed ID: 34087992)
21. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
[TBL] [Abstract][Full Text] [Related]
22. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
[TBL] [Abstract][Full Text] [Related]
23. Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing.
Bonnycastle LL; Swift AJ; Mansell EC; Lee A; Winnicki E; Li ES; Robertson CC; Parsons VA; Huynh T; Krilow C; Mohlke KL; Erdos MR; Narisu N; Collins FS
CRISPR J; 2024 Feb; 7(1):53-67. PubMed ID: 38353623
[TBL] [Abstract][Full Text] [Related]
24. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
25. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
[TBL] [Abstract][Full Text] [Related]
26. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
27. Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss.
Stojkovic M; Han D; Jeong M; Stojkovic P; Stankovic KM
Stem Cells; 2021 Jun; 39(6):673-696. PubMed ID: 33586253
[TBL] [Abstract][Full Text] [Related]
28. Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions.
Kamiya D; Yamashita T; Akaboshi T; Yamaguchi Y; Toyooka Y; Ikeya M
Stem Cell Res; 2022 Apr; 60():102704. PubMed ID: 35176664
[TBL] [Abstract][Full Text] [Related]
29. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
30. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
[TBL] [Abstract][Full Text] [Related]
31. Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing.
Houweling PJ; Crossman V; Tiong CF; Coles CA; Taylor RL; Clayton JS; Graham A; Vlahos K; Howden SE; North KN
Stem Cell Res; 2024 Mar; 75():103313. PubMed ID: 38277710
[TBL] [Abstract][Full Text] [Related]
32. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
Alagoz M; Kherad N
Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
[TBL] [Abstract][Full Text] [Related]
33. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.
Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K
CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes.
Gao Y; Wu S; Pan J; Zhang K; Li X; Xu Y; Jin C; He X; Shi J; Ma L; Wu F; Yao Y; Wang P; He Q; Lan F; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):708-720. PubMed ID: 33216174
[TBL] [Abstract][Full Text] [Related]
35. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the human GnRH neuron developmental transcriptome using a
Lund C; Yellapragada V; Vuoristo S; Balboa D; Trova S; Allet C; Eskici N; Pulli K; Giacobini P; Tuuri T; Raivio T
Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996360
[TBL] [Abstract][Full Text] [Related]
37. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
[TBL] [Abstract][Full Text] [Related]
38. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease.
Mehmood A; Ali W; Din ZU; Song S; Sohail M; Shah W; Guo J; Guo RY; Ilahi I; Shah S; Al-Shaebi F; Zeb L; Asiamah EA; Al-Dhamin Z; Bilal H; Li B
Brain Behav; 2021 Aug; 11(8):e2280. PubMed ID: 34291612
[TBL] [Abstract][Full Text] [Related]
39. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
